Form 4 for IKT Inhibikase Therapeutics, Inc.
Accepted 2024-10-23 00:00:00 ET · period of report 2024-10-21 · accession 0000950170-24-116783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-23 | 2024-10-21 | IKT | Kush Arvind | Dir | P - Purchase | $1.37 | +145.0K | 145.0K | New | +$198.7K |
| D | 2024-10-23 | 2024-10-21 | IKT | Kush Arvind | Dir | A - Grant | $0.00 | +60.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-21 | P | A | 145,000 | $1.37 | 145,000 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-10-21 | A | A | 60,000 | $0.00 | 60,000 | D | $2.22 · — to 2034-10-21 | 60,000 Common Stock | (F1) The option shares vest 50% on each of the first two anniversaries of October 21, 2024. |